(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Giga, 8×8, and DouYu.

Rank Financial Asset Price Change Updated (EST)
1 Giga (GIGA) 1.40 33.33% 2022-08-31 11:49:16
2 8×8 (EGHT) 5.27 11.18% 2022-08-30 22:42:14
3 DouYu (DOYU) 1.49 9.51% 2022-08-31 14:19:03
4 Snap (SNAP) 10.94 9.34% 2022-08-31 14:53:37
5 Geron Corporation (GERN) 2.50 8.78% 2022-08-31 11:47:16
6 Canaan (CAN) 3.68 7.92% 2022-08-31 14:48:26
7 Bilibili (BILI) 24.97 7.86% 2022-08-31 14:54:17
8 Evoke Pharma (EVOK) 2.84 7.58% 2022-08-31 01:42:15
9 Futu Holdings (FUTU) 49.35 7.55% 2022-08-31 14:47:12
10 Zai Lab (ZLAB) 46.63 7.54% 2022-08-31 14:55:27

The three biggest losers today are DURECT Corporation, Hewlett, and Eagle Bulk Shipping.

Rank Financial Asset Price Change Updated (EST)
1 DURECT Corporation (DRRX) 0.72 -8.17% 2022-08-30 19:15:06
2 Hewlett (HPQ) 28.73 -7.62% 2022-08-31 14:56:19
3 Eagle Bulk Shipping (EGLE) 42.65 -7.26% 2022-08-30 22:43:14
4 Novavax (NVAX) 33.05 -6.16% 2022-08-31 14:59:09
5 Best Buy Co. (BBY) 70.81 -5.45% 2022-08-31 14:53:01
6 Gap (GPS) 9.15 -5.43% 2022-08-31 14:58:46
7 GSI Technology (GSIT) 3.33 -5.4% 2022-08-31 15:14:06
8 LendingTree (TREE) 30.80 -5.08% 2022-08-31 14:46:47
9 Second Sight Medical Products (EYES) 4.14 -5.05% 2022-08-31 03:08:06
10 CrowdStrike Holdings (CRWD) 183.77 -4.93% 2022-08-31 14:54:26

Winners today

1. Giga (GIGA) – 33.33%

Giga-tronics Incorporated and its subsidiaries develop and produce electronic equipment for military and airborne operations in the United States as well as internationally. The company operates in two divisions, Microsource Division and the Giga-tronics Division. It develops microwave components, Band Reject filters for RADAR/EW to solve interference issues in RADAR/EW application. The company also develops, produces, and sells functional testing systems to support the defense electronic market’s RADAR/EW equipment. It serves the prime defense contractors as well as research institutes and the Armed Services. Giga-tronics Incorporated, which was founded in 1980, is based in Dublin (California).

NASDAQ ended the session with Giga rising 33.33% to $1.40 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ fell 0.56% to $11,816.20, after three consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Giga is 100 which is 87.08% below its average volume of 774.

Giga’s last close was $1.05, 75.41% under its 52-week high of $4.27.

Giga’s Revenue

Year-on-year quarterly revenue growth declined by 47.4%, now sitting on 9.03M for the twelve trailing months.

Giga’s Stock Yearly Top and Bottom Value

Giga’s stock is valued at $1.40 at 17:32 EST, way under its 52-week high of $4.27 and way above its 52-week low of $0.60.

Giga’s Moving Average

Giga’s value is way higher than its 50-day moving average of $1.22 and way under its 200-day moving average of $2.14.

More news about Giga.

2. 8×8 (EGHT) – 11.18%

8×8, Inc. provides voice, video, chat, contact center, and enterprise-class application programmable interface (API) Software-as-a-Service solutions for small and mid-size businesses, mid-market and larger enterprises, government agencies, and other organizations worldwide. It offers services such as unified communications and team collaboration. It provides 8×8 Work, a self-contained end-to-end united communications solution that delivers enterprise voice with public switched telephone network connectivity, video meetings, and unified messaging, as well as direct messages, public and private team messaging rooms, and short and multimedia services; 8×8 Contact Center, a multi-channel cloud-based contact center solution; and 8×8 CPaaS, a set of global communications Platform-as-a-Service. It also provides X1 throughX4 as well as X5 to X8 which offer enterprise-grade voice and unified communications. The company markets its services through third-party leads, search engine optimization, industry conferences and trade shows. It was founded in 1987 in Campbell, California.

NASDAQ ended the session with 8×8 jumping 11.18% to $5.27 on Wednesday, following the last session’s upward trend. NASDAQ slid 0.56% to $11,816.20, after three successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for 8×8 is 4061840 which is 80.84% above its average volume of 2246000.

8×8’s last close was $5.27, 79.72% below its 52-week high of $25.99.

The company’s growth estimates for the present quarter and the next is 200% and 150%, respectively.

8×8’s Revenue

Year-on-year quarterly revenue growth grew by 26.5%, now sitting on 677.42M for the twelve trailing months.

8×8’s Stock Yearly Top and Bottom Value

8×8’s stock is valued at $5.27 at 17:32 EST, way under its 52-week high of $25.99 and way above its 52-week low of $4.22.

8×8’s Moving Average

8×8’s value is above its 50-day moving average of $5.13 and way under its 200-day moving average of $11.20.

More news about 8×8.

3. DouYu (DOYU) – 9.51%

DouYu International Holdings Limited operates, along with its subsidiaries on mobile and PC, a platform that offers interactive games as well as entertainment and live streaming in China. The platform allows game publishers and players to connect with their developers, as well as advertisers and spectators. It also sponsors eSports players and organises eSports tournaments. It also streams other entertainment content, including talent shows, music and outdoor. The company also records video clips and makes it available to users for replays. It allows streamers and viewers to upload and edit short videos. DouYu International Holdings Limited, a company based in Wuhan in the People’s Republic of China was established in 2014.

NASDAQ ended the session with DouYu rising 9.51% to $1.49 on Wednesday, after four consecutive sessions in a row of gains. NASDAQ slid 0.56% to $11,816.20, after three consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for DouYu is 1978820 which is 41.92% above its average volume of 1394260.

DouYu’s last close was $1.36, 70.18% below its 52-week high of $4.56.

DouYu’s Sales

DouYu’s sales growth is a negative 24.6% for the ongoing quarter and a decline by 27.4% for the next. The company’s growth estimates for the present quarter is a negative 50% and positive 20% for the next.

DouYu’s Revenue

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 9.17B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DouYu’s stock is considered to be oversold (<=20).

DouYu’s Stock Yearly Top and Bottom Value

DouYu’s stock is valued at $1.49 at 17:32 EST, way under its 52-week high of $4.56 and way above its 52-week low of $1.12.

DouYu’s Moving Average

DouYu’s value is way above its 50-day moving average of $1.27 and way below its 200-day moving average of $2.18.

More news about DouYu.

4. Snap (SNAP) – 9.34%

Snap Inc. is a North American, European, and international camera company. Snapchat is a smartphone application that allows users to share short video and image messages through Snapchat. The company also offers Spectacles which connects to Snapchat and takes photos and videos from a human perspective. It also sells advertising products such as AR ads and Snap ads. These include single images or video ads, story advertisements, collection ads and dynamic ads. In September 2016, Snap Inc. was changed to Snapchat Inc. Snap Inc. was established in 2010, and its headquarters are in Santa Monica, California.

NYSE ended the session with Snap rising 9.34% to $10.94 on Wednesday while NYSE fell 0.87% to $14,801.25.

Volume

Today’s last reported volume for Snap is 190144000 which is 263.36% above its average volume of 52328300.

Snap’s last close was $10.01, 87.99% under its 52-week high of $83.34.

News about Snap today

  • Snap stock news and forecast: SNAP sells off 7% after cutting 20% of workforce. According to today’s article on FXStreet, "In fact, further news arrivedthat Snap is letting go of a surprising 20% of its workforce. ", "Essentially, Snap is in the midst of downsizing due to poor recent digital advertising sales and an uncertain outlook moving forward. "

The company’s growth estimates for the current quarter and the next is a negative 80% and a negative 41.2%, respectively.

Snap’s Revenue

Year-on-year quarterly revenue growth grew by 38.1%, now sitting on 4.41B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Snap’s stock is considered to be overbought (>=80).

Snap’s Stock Yearly Top and Bottom Value

Snap’s stock is valued at $10.94 at 17:32 EST, way under its 52-week low of $12.55.

Snap’s Moving Average

Snap’s worth is way under its 50-day moving average of $25.56 and way under its 200-day moving average of $44.78.

More news about Snap.

5. Geron Corporation (GERN) – 8.78%

Geron Corporation is a clinical biopharmaceutical company in late stage development. It focuses its efforts on developing and commercializing therapeutics to treat myeloid hematologic cancers. The company is currently in phase 3 clinical trials for imetelstat (a telomerase inhibition) that inhibits uncontrolled proliferation and malignant stem cells and progenitor cell growth in hematologic myeloid cancers. It treats low and intermediate-1 risk myelodysplastic disorders and high-risk myelofibrosis. Foster City is the headquarters of this company, which was founded in 1990.

NASDAQ ended the session with Geron Corporation jumping 8.78% to $2.50 on Wednesday while NASDAQ fell 0.56% to $11,816.20.

Volume

Today’s last reported volume for Geron Corporation is 2633680 which is 22.69% below its average volume of 3406700.

Geron Corporation’s last close was $2.30, 13.86% under its 52-week high of $2.67.

Geron Corporation’s Sales

Geron Corporation’s sales growth is 2.8% for the present quarter and 37.5% for the next.

Geron Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 10.2%, now sitting on 1.38M for the twelve trailing months.

Geron Corporation’s Stock Yearly Top and Bottom Value

Geron Corporation’s stock is valued at $2.50 at 17:33 EST, under its 52-week high of $2.67 and way above its 52-week low of $0.99.

Geron Corporation’s Moving Average

Geron Corporation’s value is way higher than its 50-day moving average of $1.95 and way above its 200-day moving average of $1.45.

More news about Geron Corporation.

6. Canaan (CAN) – 7.92%

Canaan Inc. is involved in research, development, and sales of integrated circuits (ICs) final mining equipment products. It integrates IC products for Bitcoin mining and other related components primarily from the People’s Republic of China. The company is involved in manufacturing and distributing mining equipment spare parts. Northern Data AG is the company’s strategic partner in artificial intelligence, blockchain technology and datacenter operation. Canaan Inc. is located in Beijing in the People’s Republic of China.

NASDAQ ended the session with Canaan rising 7.92% to $3.68 on Wednesday while NASDAQ fell 0.56% to $11,816.20.

Volume

Today’s last reported volume for Canaan is 1389420 which is 33.58% below its average volume of 2092150.

Canaan’s last close was $3.41, 69.53% below its 52-week high of $11.19.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 5611.9%, now sitting on 4.99B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Canaan’s stock is considered to be overbought (>=80).

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $3.68 at 17:33 EST, way under its 52-week high of $11.19 and way above its 52-week low of $2.56.

Canaan’s Moving Average

Canaan’s value is higher than its 50-day moving average of $3.61 and way under its 200-day moving average of $5.26.

More news about Canaan.

7. Bilibili (BILI) – 7.86%

Bilibili Inc. offers online entertainment for young people in China’s People’s Republic of China. The platform provides a variety of content including mobile games and video services as well as value-added and ACG-related audio and comic content. It offers video services that include occupationally-generated videos and professional user videos. Bilibili Inc. was established in Shanghai, People’s Republic of China in 2009.

NASDAQ ended the session with Bilibili rising 7.86% to $24.97 on Wednesday, after three sequential sessions in a row of losses. NASDAQ fell 0.56% to $11,816.20, after three consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Bilibili is 5264480 which is 8.38% below its average volume of 5746570.

Bilibili’s last close was $23.15, 75.23% under its 52-week high of $93.47.

Bilibili’s Sales

Bilibili’s sales growth is 7.4% for the current quarter and 4.9% for the next. The company’s growth estimates for the current quarter is a negative 82.9% and positive 7.7% for the next.

Bilibili’s Revenue

Year-on-year quarterly revenue growth grew by 29.6%, now sitting on 20.54B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bilibili’s stock is considered to be overbought (>=80).

Bilibili’s Stock Yearly Top and Bottom Value

Bilibili’s stock is valued at $24.97 at 17:33 EST, way below its 52-week high of $93.47 and way above its 52-week low of $14.93.

Bilibili’s Moving Average

Bilibili’s value is under its 50-day moving average of $25.32 and way below its 200-day moving average of $33.42.

More news about Bilibili.

8. Evoke Pharma (EVOK) – 7.58%

Evoke Pharma, Inc. is a specialty pharmaceutical firm that focuses primarily on developing and marketing drugs to treat gastroenterological diseases and disorders. Gimoti is a nasal spray containing metoclopramide that treats symptoms of acute and recurrent diabetes gastroparesis. It has successfully completed its Phase 3 clinical trials. It sells its products to internal medicine specialists and primary care doctors, as well as select health care professionals. Evoke Pharma, Inc., was founded in 2007 in Solana Beach, California.

NASDAQ ended the session with Evoke Pharma jumping 7.58% to $2.84 on Wednesday, after two successive sessions in a row of gains. NASDAQ dropped 0.56% to $11,816.20, after three sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Evoke Pharma is 24547 which is 97.18% below its average volume of 871358.

Evoke Pharma’s last close was $2.84, 83.68% below its 52-week high of $17.40.

Evoke Pharma’s Sales

Evoke Pharma’s sales growth is 144.7% for the present quarter and a decline by 19.4% for the next. The company’s growth estimates for the current quarter and the next is 28.6% and 16.7%, respectively.

Evoke Pharma’s Revenue

Year-on-year quarterly revenue growth grew by 362.7%, now sitting on 1.95M for the twelve trailing months.

Evoke Pharma’s Stock Yearly Top and Bottom Value

Evoke Pharma’s stock is valued at $2.84 at 17:33 EST, way below its 52-week high of $17.40 and way higher than its 52-week low of $2.03.

Evoke Pharma’s Moving Average

Evoke Pharma’s value is below its 50-day moving average of $3.01 and way below its 200-day moving average of $5.37.

More news about Evoke Pharma.

9. Futu Holdings (FUTU) – 7.55%

Futu Holdings Limited is an online broker and wealth management company in Hong Kong. It offers trading, clearing and settlement services, margin financing, securities lending and services for stock yield enhancement. The company also provides online wealth management services through Futumoney Plus’ Futubull platform and its moomoo platform. These platforms provide access to mutual funds and private bonds, market data, information services, and NiuNiu community, where clients and users can share their insights and ask questions. The company also offers initial public offering subscriptions and employee share options plan solutions to corporate clients. Futu Holdings Limited, which was established in 2007, is located in Hong Kong.

NASDAQ ended the session with Futu Holdings jumping 7.55% to $49.35 on Wednesday while NASDAQ slid 0.56% to $11,816.20.

Volume

Today’s last reported volume for Futu Holdings is 5918950 which is 76.56% above its average volume of 3352350.

Futu Holdings’s last close was $45.89, 61.56% under its 52-week high of $119.38.

The company’s growth estimates for the current quarter and the next is 556.2% and 320%, respectively.

Futu Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 37.9%, now sitting on 6.74B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Futu Holdings’s stock is considered to be oversold (<=20).

Futu Holdings’s Stock Yearly Top and Bottom Value

Futu Holdings’s stock is valued at $49.35 at 17:33 EST, way below its 52-week high of $119.38 and way above its 52-week low of $21.23.

Futu Holdings’s Moving Average

Futu Holdings’s worth is way higher than its 50-day moving average of $44.31 and way higher than its 200-day moving average of $43.69.

More news about Futu Holdings.

10. Zai Lab (ZLAB) – 7.54%

Zai Lab Limited is a company that develops and markets therapies for oncology and autoimmune disorders. It also has a focus in neuroscience. Zejula is a once daily small-molecule, polymerase 1/2 inhibitor. Optune delivers treatment fields to tumors. NUZYRA treats skin structures and acute bacterial infections. Qinlock can treat gastrointestinal tumors. Odronextamab is also developed to treat diffuse large B cell lymphoma and other types of B-cell lymphomas. Repotrectinib (a tyrosinekinase inhibitor) targets ROS1 or TRK A/B/C for patients who have been treated with TKI. Margetuximab can be used to treat breast cancer and stomach cancer. Adagrasib treats KRAS G12C-mutated NSCLC. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Elzovantinib, an orally bioavailable multi-targeted kinase inhibitor; Tebotelimab, a tetravalent IgG4 monoclonal antibody; Retifanlimab that inhibits interactions between PD-1 and its ligands; ZL-2309, an orally active, selective, and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor; ZL-1201, a humanized IgG4 monoclonal antibody; Efgartigimod to reduce disease-causing immunoglobulin G antibodies; ZL-1102, a human nanobody targeting interleukin- 17A; KarXT for the treatment of psychiatric and neurological conditions; ZL-2313, an investigational inhibitor of triple-mutant EGFR harboring; ZL-2314, an investigational inhibitor of double-mutant EGFR harboring; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited, a Shanghai-based company was established in 2013.

NASDAQ ended the session with Zai Lab rising 7.54% to $46.63 on Wednesday while NASDAQ dropped 0.56% to $11,816.20.

Volume

Today’s last reported volume for Zai Lab is 279854 which is 50.44% below its average volume of 564695.

Zai Lab’s last close was $43.36, 71.63% below its 52-week high of $152.82.

Zai Lab’s Sales

Zai Lab’s sales growth is 56.6% for the present quarter and 37.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 66.7% and 40.9%, respectively.

Zai Lab’s Revenue

Year-on-year quarterly revenue growth grew by 132.4%, now sitting on 170.93M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zai Lab’s stock is considered to be overbought (>=80).

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $46.63 at 17:33 EST, way below its 52-week high of $152.82 and way above its 52-week low of $22.51.

Zai Lab’s Moving Average

Zai Lab’s worth is way above its 50-day moving average of $40.00 and under its 200-day moving average of $47.33.

More news about Zai Lab.

Losers Today

1. DURECT Corporation (DRRX) – -8.17%

DURECT Corporation is a biopharmaceutical firm that develops drugs based on the company’s epigenetic regulators and pharmaceutical programs. ALZET is a product line of ALZET osmotic pumps, accessories, and equipment that are used in research on mice, rats and other laboratory animals. The company also developed larsucosterol, (DUR-928), an orally bioavailable, endogenous small molecule. This is currently in Phase IIb clinical trials to regulate lipid metabolism and stress responses. It has completed Phase Ib clinical trials to treat nonalcoholic steatohepatitis patients. The company also offers POSIMIR (a post-surgical pain medication that delivers bupivacaine for up to seven days in adults) and Methydur, which treats attention deficit hyperactivity disorder. The company markets its ALZET products through direct sales in the United States as well as via a network distributors in Japan and Europe. Strategic collaborations and other agreements have been made with Indivior UK Ltd. and Virginia Commonwealth University Intellectual Property Foundation. DURECT Corporation was established in 1998. It is located in Cupertino in California.

NASDAQ ended the session with DURECT Corporation sliding 8.17% to $0.72 on Wednesday while NASDAQ slid 0.56% to $11,816.20.

Volume

Today’s last reported volume for DURECT Corporation is 423389 which is 59.34% below its average volume of 1041520.

DURECT Corporation’s last close was $0.72, 50.04% under its 52-week high of $1.44.

DURECT Corporation’s Sales

DURECT Corporation’s sales growth is 568.2% for the current quarter and a decline by 42.6% for the next. The company’s growth estimates for the current quarter is 75% and a drop 66.7% for the next.

DURECT Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 13.45M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DURECT Corporation’s stock is considered to be overbought (>=80).

DURECT Corporation’s Stock Yearly Top and Bottom Value

DURECT Corporation’s stock is valued at $0.72 at 17:33 EST, way below its 52-week high of $1.44 and way higher than its 52-week low of $0.36.

DURECT Corporation’s Moving Average

DURECT Corporation’s value is way higher than its 50-day moving average of $0.58 and higher than its 200-day moving average of $0.67.

More news about DURECT Corporation.

2. Hewlett (HPQ) – -7.62%

HP Inc. offers personal computing, access devices and imaging products. It also provides services internationally. There are three main segments to the company: Personal Systems and Printing. Corporate Investments is another. Personal Systems offers commercial and personal notebook and desktop computers as well as thin clients and commercial mobility devices. It also sells retail point-of sale systems, display and peripherals, software support and other services. The Printing segment offers commercial and consumer printer supplies, services, and hardware. Corporate Investments is responsible for HP Labs, business incubation and investment projects. This segment serves individuals, medium and large-sized companies, as well as customers from the education, government and health sectors. In October 2015, the company changed its name from Hewlett-Packard Company to HP Inc. HP Inc. was established in 1939. Its headquarters are in Palo Alto in California.

NYSE ended the session with Hewlett dropping 7.62% to $28.73 on Wednesday, after two consecutive sessions in a row of losses. NYSE dropped 0.87% to $14,801.25, after three sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Hewlett is 24081500 which is 180.69% above its average volume of 8579230.

Hewlett’s last close was $31.10, 19.2% under its 52-week high of $38.49.

The company’s growth estimates for the ongoing quarter is 43.5% and a drop 1.1% for the next.

Hewlett’s Revenue

Year-on-year quarterly revenue growth grew by 7%, now sitting on 62.07B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Hewlett’s stock is considered to be overbought (>=80).

Hewlett’s Stock Yearly Top and Bottom Value

Hewlett’s stock is valued at $28.73 at 17:33 EST, way under its 52-week high of $38.49 and way above its 52-week low of $23.12.

Hewlett’s Moving Average

Hewlett’s worth is under its 50-day moving average of $31.65 and below its 200-day moving average of $30.67.

More news about Hewlett.

3. Eagle Bulk Shipping (EGLE) – -7.26%

Eagle Bulk Shipping Inc. is involved in ocean shipping dry bulk cargoes around the world. It charters and manages dry bulk vessels to transport various bulk cargoes such as iron ore, coke, grain, fertilizers and steel products. The company serves producers, traders and end-users. The company had 53 vessels in its fleet as of December 31, 2021. Eagle Bulk Shipping Inc. is located in Stamford Connecticut.

NASDAQ ended the session with Eagle Bulk Shipping falling 7.26% to $42.65 on Wednesday while NASDAQ slid 0.56% to $11,816.20.

Volume

Today’s last reported volume for Eagle Bulk Shipping is 605613 which is 43.77% above its average volume of 421233.

Eagle Bulk Shipping’s last close was $42.65, 45.84% under its 52-week high of $78.75.

Eagle Bulk Shipping’s Sales

Eagle Bulk Shipping’s sales growth is 44.2% for the current quarter and 17.6% for the next. The company’s growth estimates for the present quarter and the next is 86.3% and 13.7%, respectively.

Eagle Bulk Shipping’s Revenue

Year-on-year quarterly revenue growth grew by 90.9%, now sitting on 682.36M for the twelve trailing months.

Eagle Bulk Shipping’s Stock Yearly Top and Bottom Value

Eagle Bulk Shipping’s stock is valued at $42.65 at 17:33 EST, way under its 52-week high of $78.75 and way higher than its 52-week low of $36.21.

Eagle Bulk Shipping’s Moving Average

Eagle Bulk Shipping’s value is way below its 50-day moving average of $49.80 and way below its 200-day moving average of $53.49.

More news about Eagle Bulk Shipping.

4. Novavax (NVAX) – -6.16%

Novavax, Inc. is a biotechnology firm that focuses on vaccine development and commercialization. This company protects against serious diseases such as HIV and addresses health care needs. Among the vaccine candidates are NVX–CoV2373, a candidate coronavirus vaccine, which is currently in 2 Phase III trials and 1 Phase IIb trial. NanoFlu is a candidate nanoparticle seasonal quadrivalent flu vaccine that is currently in Phase 3. ResVax is a candidate respiratory syncytial viral (RSV), fusion (F-) protein nanoparticle vaccine. The company is currently developing RSV F vaccine, which is being tested in Phase II clinical trials for adults aged 60 years or older. It also has a Phase I clinical trial in pediatrics. Takeda Pharmaceutical Company Limited has signed a cooperation agreement for the production, commercialization, and development of NVXCoV2373 (a COVID-19 candidate vaccine). Novavax, Inc., was founded in 1987. It is located in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax sliding 6.16% to $33.05 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.56% to $11,816.20, after three sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Novavax is 4132800 which is 43.44% below its average volume of 7307880.

Novavax’s last close was $35.22, 87.32% under its 52-week high of $277.80.

The company’s growth estimates for the present quarter and the next is 215.8% and 247.6%, respectively.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 57.4%, now sitting on 1.4B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be overbought (>=80).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $33.05 at 17:33 EST, under its 52-week low of $34.57.

Novavax’s Moving Average

Novavax’s worth is way under its 50-day moving average of $51.64 and way below its 200-day moving average of $86.49.

More news about Novavax.

5. Best Buy Co. (BBY) – -5.45%

Best Buy Co., Inc. sells technology products across the United States. There are two main segments to the company: Domestic and International. The company’s stores sell computing products such as notebooks and desktops. Mobile phones with related network commissions and networking products are also available. Smartwatches and tablets include e-readers and tablet covers. Consumer electronics can be used for digital imaging, fitness, home theatre, audio, headphones, speakers and other smart home products. It also sells appliances such as laundry machines, dishwashers and ovens as well as coffee and tea makers. It also offers consultation, delivery and repair services, as well as technical support. It sells its products via stores and online under Best Buy Ads and Best Buy Business. It had 1,144 locations as of January 30, 2022. The former name of the company was Sound of Music, Inc. It was founded in 1966, and its headquarters are in Richfield Minnesota.

NYSE ended the session with Best Buy Co. dropping 5.45% to $70.81 on Wednesday while NYSE slid 0.87% to $14,801.25.

Volume

Today’s last reported volume for Best Buy Co. is 5171330 which is 69.29% above its average volume of 3054560.

Best Buy Co.’s last close was $74.89, 47.25% under its 52-week high of $141.97.

The company’s growth estimates for the ongoing quarter and the next is a negative 11.7% and a negative 16.7%, respectively.

Best Buy Co.’s Revenue

Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 52.28B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Best Buy Co.’s stock is considered to be overbought (>=80).

Best Buy Co.’s Stock Yearly Top and Bottom Value

Best Buy Co.’s stock is valued at $70.81 at 17:33 EST, way under its 52-week low of $95.93.

Best Buy Co.’s Moving Average

Best Buy Co.’s worth is way under its 50-day moving average of $118.01 and way under its 200-day moving average of $115.28.

More news about Best Buy Co..

6. Gap (GPS) – -5.43%

Gap, Inc. is an apparel retailer. It offers clothing, accessories and personal care products to men and women of all ages under Old Navy, Gap and Banana Republic brands. The company’s products include jeans, tees and fleeces as well as eyewear, jewelry and handbags. It also offers fitness and lifestyle products that can be used in training, sport, travel and other everyday activities, such for girls and women. It sells its products via company-operated shops, franchise stores and websites, as well as through third-party agreements, catalogs, catalogues, and online. Franchise agreements are made with non-affiliated franchisees in order to open Old Navy, Gap and Athleta stores, as well as websites and other locations throughout Asia, Europe and Latin America. The company owned 2,835 stores, and had 564 franchise shops as of December 31, 2021. The company also sells its products via e-commerce websites. The Gap, Inc., was founded in 1969. It is located in San Francisco, California.

NYSE ended the session with Gap falling 5.43% to $9.15 on Wednesday, following the last session’s upward trend. NYSE dropped 0.87% to $14,801.25, after three sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Gap is 7086530 which is 19.23% below its average volume of 8774570.

Gap’s last close was $9.67, 64.44% under its 52-week high of $27.19.

The company’s growth estimates for the ongoing quarter and the next is a negative 107.1% and a negative 44.4%, respectively.

Gap’s Revenue

Year-on-year quarterly revenue growth declined by 12.9%, now sitting on 16.16B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Gap’s stock is considered to be overbought (>=80).

Gap’s Stock Yearly Top and Bottom Value

Gap’s stock is valued at $9.15 at 17:34 EST, way below its 52-week high of $27.19 and way above its 52-week low of $7.79.

Gap’s Moving Average

Gap’s worth is under its 50-day moving average of $9.41 and way under its 200-day moving average of $13.88.

More news about Gap.

7. GSI Technology (GSIT) – -5.4%

GSI Technology, Inc., a fabless silicon company, designs, produces, and markets semiconductor memories to military, industrial, medical, aerospace, commercial, and other customers worldwide. Associative processing units are products that use similarity search to find answers in visual searches for ecommerce and cyber security. It also offers SRAM products such as SyncBurst, which can be used for microprocessor cache, as well other applications. SigmaQuad, SigmaDDR, and SigmaQuad products are available to meet the requirements for networking and telecom. Low latency DRAMs provide advanced data networking solutions. Asynchronous is a main memory that stores small, cacheless embedded processors, for use in industrial electronics, measurement and cost-sensitive network equipment. It also offers radiation-resistant and radiation-hardened SRAMs that are suitable for military and aerospace applications such as missiles and networking satellites. The company’s products can be found in the products of our OEM customers, which include routers, switches, and other networking products. They also have audio/video processing, test and measurement applications that consist of high-speed testers. Automotive applications such as smart cruise control and medical applications such as ultrasound and CAT scanning equipment. Its products are sold through independent distributors and sales reps. GSI Technology, Inc. is a California-based company that was founded in 1995.

NASDAQ ended the session with GSI Technology dropping 5.4% to $3.33 on Wednesday, following the last session’s downward trend. NASDAQ dropped 0.56% to $11,816.20, after three successive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for GSI Technology is 39973 which is 334.44% above its average volume of 9201.

GSI Technology’s last close was $3.52, 43.32% under its 52-week high of $6.21.

GSI Technology’s Revenue

Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 33.5M for the twelve trailing months.

GSI Technology’s Stock Yearly Top and Bottom Value

GSI Technology’s stock is valued at $3.33 at 17:34 EST, way below its 52-week high of $6.21 and way higher than its 52-week low of $2.99.

GSI Technology’s Moving Average

GSI Technology’s worth is way below its 50-day moving average of $3.73 and way under its 200-day moving average of $4.13.

More news about GSI Technology.

8. LendingTree (TREE) – -5.08%

LendingTree, Inc. operates an online platform for consumers in the United States through its subsidiary, LT Intermediate Company, LLC. The company operates in three areas: Consumer, Home and Insurance. Refinance, reverse mortgage and purchase mortgage are all available in the Home segment. Lines of credit and brokerage services can also be offered. Credit cards, personal, small-business, student and auto loans are all available in the Consumer segment. Deposit accounts can also be offered. Information, tools and access to insurance products are available through the Insurance segment. This allows consumers to match with lead aggregators and receive insurance quotes. LendingTree, Inc. operates Student Loan Hero, a website to help student loan borrowers manage student loans; QuoteWizard.com, a website for comparison of insurance; ValuePenguin, a website offering objective analysis to consumers on a variety of financial topics, from credit cards to insurance; and Stash, a platform for consumer banking and investing that provides a range personal investment accounts, Roth IRAs, custodial accounts, as well as banking services, such checking accounts, debit cards and stock-back rewards programme. In January 2015, the company, formerly Tree.com, Inc., was changed to LendingTree, Inc. LendingTree, Inc. is located in Charlotte, North Carolina.

NASDAQ ended the session with LendingTree dropping 5.08% to $30.80 on Wednesday, after three sequential sessions in a row of losses. NASDAQ fell 0.56% to $11,816.20, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for LendingTree is 234841 which is 7.26% below its average volume of 253234.

LendingTree’s last close was $32.45, 80.93% below its 52-week high of $170.20.

LendingTree’s Sales

LendingTree’s sales growth is a negative 13.4% for the ongoing quarter and a decline by 8.9% for the next. The company’s growth estimates for the ongoing quarter is a negative 21.3% and positive 350% for the next.

LendingTree’s Revenue

Year-on-year quarterly revenue growth declined by 3%, now sitting on 1.1B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

LendingTree’s stock is considered to be overbought (>=80).

LendingTree’s Stock Yearly Top and Bottom Value

LendingTree’s stock is valued at $30.80 at 17:34 EST, under its 52-week low of $33.06.

LendingTree’s Moving Average

LendingTree’s worth is way below its 50-day moving average of $45.35 and way below its 200-day moving average of $90.52.

More news about LendingTree.

9. Second Sight Medical Products (EYES) – -5.05%

Second Sight Medical Products, Inc. designs, produces, and sells implantable vision prosthetics. These devices are designed to provide artificial sight to the blind. The company develops technology to help the sight impaired population. Orion Visual Cortical Prosthesis System is an implanted cortical stimulation system that provides artificial vision for blind individuals. It can be used to treat a variety of conditions, such as glaucoma and diabetic retinopathy. It was established in 1998 in Sylmar in California.

NASDAQ ended the session with Second Sight Medical Products dropping 5.05% to $4.14 on Wednesday while NASDAQ fell 0.56% to $11,816.20.

Volume

Today’s last reported volume for Second Sight Medical Products is 35771 which is 57.24% below its average volume of 83656.

Second Sight Medical Products’s last close was $4.14, 65.06% under its 52-week high of $11.85.

Second Sight Medical Products’s Stock Yearly Top and Bottom Value

Second Sight Medical Products’s stock is valued at $4.14 at 17:34 EST, way under its 52-week high of $11.85 and way higher than its 52-week low of $3.42.

Second Sight Medical Products’s Moving Average

Second Sight Medical Products’s value is way below its 50-day moving average of $5.84 and way under its 200-day moving average of $5.22.

More news about Second Sight Medical Products.

10. CrowdStrike Holdings (CRWD) – -4.93%

CrowdStrike Holdings, Inc. offers cloud-delivered protection for endpoints, cloud workloads, data, identity, as well as cloud-delivered security. The company offers managed security services, threat intelligence, managed cybersecurity services, IT operations management and threat hunting. It also manages log management. It sells cloud modules and subscriptions through direct sales, which leverages its channel partners. The company serves clients around the world. It was founded in Austin, Texas in 2011.

NASDAQ ended the session with CrowdStrike Holdings falling 4.93% to $183.77 on Wednesday while NASDAQ fell 0.56% to $11,816.20.

Volume

Today’s last reported volume for CrowdStrike Holdings is 14495400 which is 304.61% above its average volume of 3582480.

CrowdStrike Holdings’s last close was $193.29, 35.24% under its 52-week high of $298.48.

The company’s growth estimates for the current quarter and the next is 145.5% and 64.7%, respectively.

CrowdStrike Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 61.1%, now sitting on 1.64B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

CrowdStrike Holdings’s stock is considered to be overbought (>=80).

CrowdStrike Holdings’s Stock Yearly Top and Bottom Value

CrowdStrike Holdings’s stock is valued at $183.77 at 17:34 EST, way under its 52-week high of $298.48 and way higher than its 52-week low of $130.00.

CrowdStrike Holdings’s Moving Average

CrowdStrike Holdings’s worth is below its 50-day moving average of $184.36 and below its 200-day moving average of $191.61.

More news about CrowdStrike Holdings.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here